IP Library › Patent Application 13238296
Patent Application
App. No. 13/238,296

METHODS FOR REDUCING OR NEOVASCULARIZATION OR EDEMA

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/238,296
Abstract

Methods for reducing or preventing neovascularization or edema in the eye by implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.

Claims (4)

1 . A solid bioerodible implant for reducing or preventing transplant rejection in an eye of an individual, the implant comprising about 50% by weight of dexamethasone and about 50% by weight of polylactic polyglycolic acid (PLGA).

2 . A solid bioerodible implant for reducing or preventing transplant rejection in an eye of an individual, the implant comprising about 70% by weight of dexamethasone and about 30% by weight of polylactic polyglycolic acid (PLGA).

3 . A solid bioerodible implant for reducing or preventing transplant rejection in an eye of an individual, the implant comprising about 50% by weight of dexamethasone, about 15% by weight of hydroxypropyl methylcellulose (HPMC), and about 35% by weight of Resomer RG 502H PLGA.

4 . A solid bioerodible implant for reducing or preventing transplant rejection in an eye of an individual, the implant comprising about 60% by weight of dexamethasone, about 30% by weight of Resomer RG 502H PLGA, and about 10% by weight of Resomer RG 502 PLGA.